Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arthur L Shaffer

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2014
B cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infectionCaroline M Percopo, Kimberly D Dyer, Katia E Garcia-Crespo, et al.
Immunological Reviews|April 21, 2006
A library of gene expression signatures to illuminate normal and pathological lymphoid biologyArthur L Shaffer, George Wright, Liming Yang, et al.
Molecular and Cellular Biology|February 27, 2013
The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombinationBaeck-seung Lee, Joseph D Dekker, Bum-kyu Lee, et al.
Molecular and Cellular Biology|October 15, 2017
Retraction for Lee et al., "The BCL11A Transcription Factor Directly Activates RAG Gene Expression and V(D)J Recombination"Baeck-Seung Lee, Joseph D Dekker, Bum-Kyu Lee, et al.
Molecular and Cellular Biology|October 18, 2017
Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J RecombinationBaeck-Seung Lee, Bum-Kyu Lee, Vishwanath R Iyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responsesKerstin Nündel, Nathaniel M Green, Arthur L Shaffer, et al.
The Journal of Experimental Medicine|December 2, 2015
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancyPriscilla N Kelly, Donna L Romero, Yibin Yang, et al.
Blood|December 18, 2010
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expressionChristina M Annunziata, Lidia Hernandez, R Eric Davis, et al.
Molecular Cancer|November 10, 2005
Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1Seong Su Han, Arthur L Shaffer, Liangping Peng, et al.
Cancer Cell|April 2, 2013
Control of autophagic cell death by caspase-10 in multiple myelomaLaurence Lamy, Vu N Ngo, N C Tolga Emre, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2014
B cells are not essential for Lactobacillus-mediated protection against lethal pneumovirus infectionCaroline M Percopo, Kimberly D Dyer, Katia E Garcia-Crespo, et al.
Immunological Reviews|April 21, 2006
A library of gene expression signatures to illuminate normal and pathological lymphoid biologyArthur L Shaffer, George Wright, Liming Yang, et al.
Molecular and Cellular Biology|February 27, 2013
The BCL11A transcription factor directly activates RAG gene expression and V(D)J recombinationBaeck-seung Lee, Joseph D Dekker, Bum-kyu Lee, et al.
Molecular and Cellular Biology|October 15, 2017
Retraction for Lee et al., "The BCL11A Transcription Factor Directly Activates RAG Gene Expression and V(D)J Recombination"Baeck-Seung Lee, Joseph D Dekker, Bum-Kyu Lee, et al.
Molecular and Cellular Biology|October 18, 2017
Corrected and Republished from: BCL11A Is a Critical Component of a Transcriptional Network That Activates RAG Expression and V(D)J RecombinationBaeck-Seung Lee, Bum-Kyu Lee, Vishwanath R Iyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2015
Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responsesKerstin Nündel, Nathaniel M Green, Arthur L Shaffer, et al.
The Journal of Experimental Medicine|December 2, 2015
Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancyPriscilla N Kelly, Donna L Romero, Yibin Yang, et al.
Blood|December 18, 2010
A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expressionChristina M Annunziata, Lidia Hernandez, R Eric Davis, et al.
Molecular Cancer|November 10, 2005
Molecular and cytological features of the mouse B-cell lymphoma line iMycEmu-1Seong Su Han, Arthur L Shaffer, Liangping Peng, et al.
Cancer Cell|April 2, 2013
Control of autophagic cell death by caspase-10 in multiple myelomaLaurence Lamy, Vu N Ngo, N C Tolga Emre, et al.
Pageof 5